Hazel Moore, who is Chairman of FirstCapital, has recently been appointed as a Non-Executive Director on the board of British Patient Capital.

British Patient Capital was set up in 2018 to invest £2.5bn into funds supporting long-term investment in growth-stage companies across the UK, and to leverage an additional £5bn of private sector money for innovative scale-ups. Hazel’s extensive experience of working with high-growth technology companies over the last 20 years will be fundamental in her new role.

Hazel is an active advisor in the UK innovation sector. She chairs the Innovation Finance Sub-Committee for Innovate UK and was previously a Governing Board member until 2018. As well as being a current member of the Future Fifty advisory panel, Hazel was previously on the Investment Advisory Panel of the North West Fund. In the 2017 New Years’ Honours list, Hazel was awarded an OBE for services to entrepreneurship and innovation.

“I’ve worked with many growing businesses over the years and have seen first-hand the positive impact that strong, supportive financial backing can have on their ability to scale. I am delighted to work with British Patient Capital and I am excited about its potential to help accelerate high-growth UK businesses through providing a source of long-term capital.”

– Hazel Moore, Chairman at FirstCapital